Vertex Pharmaceuticals Incorporated VRTX stock has declined 4.8% over the past month. This reflects concerns over the ...
The drug maker says its treatment of a rare kidney disease met its main goal in a late-stage trial.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results